Literature DB >> 27708166

Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research.

Paul W Tetteh1, Kai Kretzschmar1, Harry Begthel1, Maaike van den Born1, Jeroen Korving1, Folkert Morsink2, Henner Farin1, Johan H van Es1, G Johan A Offerhaus2, Hans Clevers3.   

Abstract

Current mouse models for colorectal cancer often differ significantly from human colon cancer, being largely restricted to the small intestine. Here, we aim to develop a colon-specific inducible mouse model that can faithfully recapitulate human colon cancer initiation and progression. Carbonic anhydrase I (Car1) is a gene expressed uniquely in colonic epithelial cells. We generated a colon-specific inducible Car1CreER knock-in (KI) mouse with broad Cre activity in epithelial cells of the proximal colon and cecum. Deletion of the tumor suppressor gene Apc using the Car1CreER KI caused tumor formation in the cecum but did not yield adenomas in the proximal colon. Mutation of both Apc and Kras yielded microadenomas in both the cecum and the proximal colon, which progressed to macroadenomas with significant morbidity. Aggressive carcinomas with some invasion into lymph nodes developed upon combined induction of oncogenic mutations of Apc, Kras, p53, and Smad4 Importantly, no adenomas were observed in the small intestine. Additionally, we observed tumors from differentiated Car1-expressing cells with Apc/Kras mutations, suggesting that a top-down model of intestinal tumorigenesis can occur with multiple mutations. Our results establish the Car1CreER KI as a valuable mouse model to study colon-specific tumorigenesis and metastasis as well as cancer-cell-of-origin questions.

Entities:  

Keywords:  Car1; colorectal cancer; differentiated epithelial cells; gastrointestinal tract; mouse model

Mesh:

Substances:

Year:  2016        PMID: 27708166      PMCID: PMC5081651          DOI: 10.1073/pnas.1614057113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

5.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

6.  Genetically engineered models have advantages over xenografts for preclinical studies.

Authors:  Oren J Becher; Eric C Holland
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

7.  Inducible Cre mice.

Authors:  Susanne Feil; Nadejda Valtcheva; Robert Feil
Journal:  Methods Mol Biol       Date:  2009

8.  Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Authors:  Byoung-San Moon; Woo-Jeong Jeong; Jieun Park; Tae Il Kim; Do Sik Min; Kang-Yell Choi
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

Review 9.  Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium.

Authors:  N A Mabbott; D S Donaldson; H Ohno; I R Williams; A Mahajan
Journal:  Mucosal Immunol       Date:  2013-05-22       Impact factor: 7.313

10.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

View more
  22 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation.

Authors:  Jatin Roper; Tuomas Tammela; Adam Akkad; Mohammad Almeqdadi; Sebastian B Santos; Tyler Jacks; Ömer H Yilmaz
Journal:  Nat Protoc       Date:  2018-01-04       Impact factor: 13.491

3.  SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium.

Authors:  Ansu O Perekatt; Pooja P Shah; Shannon Cheung; Nidhi Jariwala; Alex Wu; Vishal Gandhi; Namit Kumar; Qiang Feng; Neeket Patel; Lei Chen; Shilpy Joshi; Anbo Zhou; M Mark Taketo; Jinchuan Xing; Eileen White; Nan Gao; Michael L Gatza; Michael P Verzi
Journal:  Cancer Res       Date:  2018-07-09       Impact factor: 12.701

4.  Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer.

Authors:  Susan Kochall; May-Linn Thepkaysone; Sebastián A García; Alexander M Betzler; Jürgen Weitz; Christoph Reissfelder; Sebastian Schölch
Journal:  J Vis Exp       Date:  2017-07-18       Impact factor: 1.355

5.  Wnt Signaling and Colorectal Cancer.

Authors:  Emma M Schatoff; Benjamin I Leach; Lukas E Dow
Journal:  Curr Colorectal Cancer Rep       Date:  2017-02-28

6.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

Review 7.  Defining key concepts of intestinal and epithelial cancer biology through the use of mouse models.

Authors:  Toby J Phesse; Victoria Marsh Durban; Owen J Sansom
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

8.  The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.

Authors:  Prashant V Bommi; Charles M Bowen; Laura Reyes-Uribe; Wenhui Wu; Hiroyuki Katayama; Pedro Rocha; Edwin R Parra; Alejandro Francisco-Cruz; Zuhal Ozcan; Elena Tosti; Jason A Willis; Hong Wu; Melissa W Taggart; Jared K Burks; Patrick M Lynch; Winfried Edelmann; Paul A Scheet; Ignacio I Wistuba; Krishna M Sinha; Samir M Hanash; Eduardo Vilar
Journal:  Cancer Res       Date:  2021-03-18       Impact factor: 12.701

9.  TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis.

Authors:  Patrizia Cammareri; David F Vincent; Michael C Hodder; Rachel A Ridgway; Claudio Murgia; Max Nobis; Andrew D Campbell; Julia Varga; David J Huels; Chithra Subramani; Katie L H Prescott; Colin Nixon; Ann Hedley; Simon T Barry; Florian R Greten; Gareth J Inman; Owen J Sansom
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

Review 10.  Reconstructing the tumor architecture into organoids.

Authors:  Zhimin Luo; Xingwu Zhou; Kalpana Mandal; Na He; Wally Wennerberg; Moyuan Qu; Xing Jiang; Wujin Sun; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2021-06-19       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.